Clinical Determinants of Disease Progression in Patients With Beta-Sarcoglycan Gene Mutations

Background: Limb-girdle muscular dystrophy 2E (LGMD 2E), recently renamed as autosomal recessive limb-girdle muscular dystrophy-4 (LGMDR4), is characterized by the lack of beta-sarcoglycan, normally expressed in skeletal muscles and cardiomyocytes. We hypothesized that progressive respiratory and le...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Giulia Bruna, Valenti, Luca, Torrente, Yvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280524/
https://www.ncbi.nlm.nih.gov/pubmed/34276533
http://dx.doi.org/10.3389/fneur.2021.657949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280524/
https://www.ncbi.nlm.nih.gov/pubmed/34276533
http://dx.doi.org/10.3389/fneur.2021.657949

Ejemplares similares